Dyne Therapeutics (DYN) EPS (Weighted Average and Diluted) (2021 - 2026)
Dyne Therapeutics (DYN) recorded quarterly EPS (Weighted Average and Diluted) of -$0.73 in Q1 2026, little changed quarter-over-quarter from -$0.73 in Q4 2025, and up 30.48% on a YoY basis from -$0.56 in Q1 2025.
Dyne Therapeutics (DYN) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Dyne Therapeutics' EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$0.73 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 30.48% year-over-year to -$0.73; the TTM figure through Mar 2026 stood at -$3.19 (up 11.14% YoY), while the FY2025 annual figure was -$3.47, down 2.97% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.73 for Q1 2026 at Dyne Therapeutics, roughly flat from -$0.73 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.69 in Q1 2022 to a low of -$1.09 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.87 across 5 years, with a median of -$0.81 in 2024.
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) tumbled 74.14% in 2022, then surged 35.19% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.73 in 2022, then tumbled by 49.32% to -$1.09 in 2023, then advanced by 19.27% to -$0.88 in 2024, then gained by 17.05% to -$0.73 in 2025, then changed by 0.0% to -$0.73 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.73 (Q1 2026), -$0.73 (Q4 2025), and -$0.76 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - | -0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.73 |
| Dec 31, 2025 | -0.73 |
| Sep 30, 2025 | -0.76 |
| Jun 30, 2025 | -0.97 |
| Mar 31, 2025 | -1.05 |
| Dec 31, 2024 | -0.88 |
| Sep 30, 2024 | -0.96 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.81 |
| Dec 31, 2023 | -1.09 |
| Sep 30, 2023 | -0.99 |
| Jun 30, 2023 | -1.08 |
| Mar 31, 2023 | -0.78 |
| Dec 31, 2022 | -0.73 |
| Sep 30, 2022 | -0.80 |
| Jun 30, 2022 | -1.01 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -1.01 |
| Sep 30, 2021 | -0.83 |
| Jun 30, 2021 | -0.58 |